These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32318863)

  • 1. Cultivation of the Next-Generation Probiotic Akkermansia muciniphila, Methods of Its Safe Delivery to the Intestine, and Factors Contributing to Its Growth In Vivo.
    Ropot AV; Karamzin AM; Sergeyev OV
    Curr Microbiol; 2020 Aug; 77(8):1363-1372. PubMed ID: 32318863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akkermansia muciniphila and host interaction within the intestinal tract.
    Karamzin AM; Ropot AV; Sergeyev OV; Khalturina EO
    Anaerobe; 2021 Dec; 72():102472. PubMed ID: 34743983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical review on the relationship of herbal medicine, Akkermansia muciniphila, and human health.
    Bu F; Zhang S; Duan Z; Ding Y; Chen T; Wang R; Feng Z; Shi G; Zhou J; Chen Y
    Biomed Pharmacother; 2020 Aug; 128():110352. PubMed ID: 32521456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of
    Hasani A; Ebrahimzadeh S; Hemmati F; Khabbaz A; Hasani A; Gholizadeh P
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34623232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of a potential and promising probiotic candidate-Akkermansia muciniphila.
    Cheng D; Xie MZ
    J Appl Microbiol; 2021 Jun; 130(6):1813-1822. PubMed ID: 33113228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel pectin-carboxymethylcellulose-based double-layered mucin/chitosan microcomposites successfully protect the next-generation probiotic Akkermansia muciniphila through simulated gastrointestinal transit and alter microbial communities within colonic ex vivo bioreactors.
    Ta LP; Corrigan S; Horniblow RD
    Int J Pharm; 2024 Nov; 665():124670. PubMed ID: 39244071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A next generation probiotic,
    Zhai Q; Feng S; Arjan N; Chen W
    Crit Rev Food Sci Nutr; 2019; 59(19):3227-3236. PubMed ID: 30373382
    [No Abstract]   [Full Text] [Related]  

  • 8. A Critical Review on Akkermansia muciniphila: Functional Mechanisms, Technological Challenges, and Safety Issues.
    Abbasi A; Bazzaz S; Da Cruz AG; Khorshidian N; Saadat YR; Sabahi S; Ozma MA; Lahouty M; Aslani R; Mortazavian AM
    Probiotics Antimicrob Proteins; 2024 Aug; 16(4):1376-1398. PubMed ID: 37432597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin degrader
    Kim S; Shin YC; Kim TY; Kim Y; Lee YS; Lee SH; Kim MN; O E; Kim KS; Kweon MN
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33678130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases.
    Zhou JC; Zhang XW
    Chin J Nat Med; 2019 Nov; 17(11):835-841. PubMed ID: 31831130
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yan J; Sheng L; Li H
    Gut Microbes; 2021; 13(1):1984104. PubMed ID: 34674606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of
    Yoshihara T; Oikawa Y; Kato T; Kessoku T; Kobayashi T; Kato S; Misawa N; Ashikari K; Fuyuki A; Ohkubo H; Higurashi T; Tateishi Y; Tanaka Y; Nakajima S; Ohno H; Wada K; Nakajima A
    Gut Microbes; 2020 Sep; 11(5):1385-1404. PubMed ID: 32515658
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    He KY; Lei XY; Wu DH; Zhang L; Li JQ; Li QT; Yin WT; Zhao ZL; Liu H; Xiang XY; Zhu LJ; Cui CY; Wang KK; Wang JH; Lv L; Sun QH; Liu GL; Xu ZX; Jian YP
    Gut Microbes; 2023 Dec; 15(2):2293312. PubMed ID: 38087436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges.
    Luo Y; Lan C; Li H; Ouyang Q; Kong F; Wu A; Ren Z; Tian G; Cai J; Yu B; He J; Wright AG
    NPJ Biofilms Microbiomes; 2022 Oct; 8(1):81. PubMed ID: 36253412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-HRMS-based metabolomics and lipidomics analyses of a novel probiotic Akkermansia Muciniphila in response to different nutritional stimulations.
    Zhang H; Zhang S; Chen L; Xu R; Zhu J
    J Microbiol Methods; 2024 Aug; 223():106975. PubMed ID: 38889842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of Akkermansia muciniphila with host-derived substances, bacteria and diets.
    Hagi T; Belzer C
    Appl Microbiol Biotechnol; 2021 Jun; 105(12):4833-4841. PubMed ID: 34125276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the probiotic
    Xu R; Zhang Y; Chen S; Zeng Y; Fu X; Chen T; Luo S; Zhang X
    Crit Rev Microbiol; 2023 Mar; 49(2):151-176. PubMed ID: 35272549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.
    Aggarwal V; Sunder S; Verma SR
    Folia Microbiol (Praha); 2022 Dec; 67(6):811-824. PubMed ID: 35596115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Scale Model and Omics Analysis of Metabolic Capacities of
    Ottman N; Davids M; Suarez-Diez M; Boeren S; Schaap PJ; Martins Dos Santos VAP; Smidt H; Belzer C; de Vos WM
    Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28687644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akkermansia muciniphila uses human milk oligosaccharides to thrive in the early life conditions in vitro.
    Kostopoulos I; Elzinga J; Ottman N; Klievink JT; Blijenberg B; Aalvink S; Boeren S; Mank M; Knol J; de Vos WM; Belzer C
    Sci Rep; 2020 Aug; 10(1):14330. PubMed ID: 32868839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.